Skip to main content
Log in

Watchful waiting cost effective after chemoradiotherapy for rectal cancer

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2019 US dollars

  2. non-operative management

References

  1. Miller JA, et al. Cost-Effectiveness and Quality-Adjusted Survival of Watch-and-Wait after Complete Response to Chemoradiotherapy for Rectal Cancer. Journal of the National Cancer Institute : 13 Jan 2020. Available from: URL: http://doi.org/10.1093/jnci/djaa003

  2. Romesser PB, et al. Nonoperative Management of Rectal Cancer Shows Cost-Effectiveness, but Can Comparative Effectiveness Be Established? Journal of the National Cancer Institute : 13 Jan 2020. Available from: URL: http://doi.org/10.1093/jnci/djaa005

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Watchful waiting cost effective after chemoradiotherapy for rectal cancer. PharmacoEcon Outcomes News 845, 32 (2020). https://doi.org/10.1007/s40274-020-6535-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6535-9

Navigation